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Self-tolerant T cells and regulatory T cells develop in the thymus. A wide variety of cell–cell
interactions in the thymus is required for the differentiation, proliferation, and repertoire
selection of T cells. Various secreted and cell surface molecules expressed in thymic
epithelial cells (TECs) mediate these processes. Moreover, cytokines expressed by cells
of hematopoietic origin regulate the cellularity of TECs. Tumor necrosis factor (TNF) family
RANK ligand, lymphotoxin, and CD40 ligand, expressed in T cells and innate lymphoid
cells (ILCs), promote the differentiation and proliferation of medullary TECs (mTECs) that
play critical roles in the induction of immune tolerance. A recent study suggests that
interleukin-22 (IL-22) produced by ILCs promotes regeneration of TECs after irradiation.
Intriguingly, tumor growth factor-β and osteoprotegerin limit cellularity of mTECs, thereby
attenuating regulatory T cell generation. We will review recent insights into the molecular
basis for cell–cell interactions regulating differentiation and proliferation of mTECs and
also discuss about a perspective on use of mathematical models for understanding this
complicated system.
Keywords: medullary thymic epithelial cells, autoimmune disease, negative feedback, mathematical modeling,
T cells, thymus
Introduction
Thymic epithelial cells (TECs) are essential for T cell development and self-tolerance induction in the
thymus (1). TECs are classified intomedullary TECs (mTECs) and cortical TECs (cTECs) according
to their localizations in the thymus.While cTECsmainly support the early differentiation and prolif-
eration of T cells and positive selection of self-MHC-restricted T cells, several lines of evidence indi-
cate critical roles of mTECs in preventing the onset of autoimmune diseases in human and mice (2).
mTECs uniquely expressmany kinds of tissue-specific self-antigens (TSAs) (2–4).mTECs expressing
high levels ofMHCclass II and co-stimulatorymolecules, such as CD80, would be capable of directly
presenting these TSAs to medullary T cells (5). Alternatively, TSAs in mTECs are transferred to
thymic dendritic cells (DCs) and indirectly presented to T cells (6, 7). When T cells recognize these
presented TSAs through high avidity interactions, they undergo apoptosis or are converted into reg-
ulatory T cells (Tregs) (2). Expression of TSAs is, in part, regulated by nuclear protein autoimmune
regulator (AIRE), and dysfunctional mutations in AIRE provoke autoimmune diseases in humans
(3, 8, 9). In addition to such roles in preventing autoimmunity, recent studies suggest that immune
tolerance to some tumors might be under the control of mTECs (10–12). Therefore, understanding
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cellular and molecular mechanisms to regulate mTEC differentia-
tion, proliferation, and apoptosis is an important issue.
Recent studies have revealed new aspects of mTEC differen-
tiation and proliferation (13–15). One recent study indicated a
newmechanism that promotes recovery of TECs following thymic
injury induced by γ-irradiation (13). In addition,molecularmech-
anisms of negative regulation in mTEC differentiation have been
reported (14, 15). In this review, we will summarize these new
findings. Moreover, these new findings together with previous
studies imply the existence of considerably more complicated
cellular and molecular mechanisms regulating mTEC cellularity
than was previously recognized. Such a sophisticated system can
ensure precise regulation of TEC functions in T cell differentia-
tion, selection, and tolerance induction. Therefore, we also present
our perspectives on howmathematicalmodelingmight contribute
to understanding regulation of TEC cellularity and functions.
Positive Regulatory Mechanisms for mTEC
Differentiation and Regeneration
Tumor Necrosis Factor Receptor Family Signaling
and NF-κB Pathways in mTEC Differentiation
Medullary TECs constitute a heterogeneous cell population under
constant differentiation (1). The roles of tumor necrosis factor
(TNF) receptor family signaling on mTEC differentiation were
previously summarized (16). Therefore, we briefly mention this
topic. Receptor activator of NF-κB (RANK), CD40, and lympho-
toxin β-receptor (LtβR), and all members of the TNF receptor
family, have been reported to promote mTEC differentiation.
RANK signaling appears to play a dominant role in the differenti-
ation ofmTECs expressing Aire (16–19). The role of CD40may be
similar to that of RANK in the postnatal period because deletion of
both RANK and CD40 signaling resulted in almost complete loss
of Aire-expressing mTECs, as compared to a partial reduction of
mature mTECs by the absence of either RANK or CD40 signaling
(16). In the embryonic thymus, only RANK signaling is active (18)
because thymic expression of CD40 ligand starts in the perinatal
period (20). LtβR might control several distinct steps in mTEC
differentiation (16, 21–23). An early study suggests that LtβR
signaling induces Aire expression (24). However, later studies did
not support the direct connection between LtβR signaling and
Aire expression (25, 26). This apparent discrepancy remains to be
solved. Moreover, some studies revealed that the absence of LtβR
signaling causes a disturbance in three-dimensional organization
of mTECs (27, 28), suggesting a distinct role of LtβR signaling
from other TNF receptor signaling.
Ligands of these TNF receptor family members are expressed
mainly in cells of hematopoietic origin. Previous studies revealed
that RANK ligand (RANKL) is expressed in innate lymphoid cells
(ILCs) and positively selected CD4+CD8  T cells (CD4SP) (16,
19). Moreover, RANKL expression was detected in fractions of
CD4 CD8  thymocytes (double negative, DN) and γδT cells (29,
30). Conditional deletion of RANKL from each cell type would
be needed to identify what types of cells are major sources of the
RANKL for mTEC differentiation unambiguously. CD40 ligand is
most highly expressed in CD4SP (19, 31). The ligand of LtβR is a
heterotrimer consisting of secreted lymphotoxinα andmembrane
bound lymphotoxin β. Expression of lymphotoxin β appears to
be high in CD4SP, CD8SP, and ILCs (19, 25, 32). Consequently,
interactions with these cells might be required for differentiation
of mTECs.
Signaling byRANK,CD40, andLtβRactivates the transcription
factor NF-κB. The NF-κB family consisting of five members (i.e.,
RelA, RelB, c-Rel, p105/p50, and p100/p52) that form hetero- and
homodimers and are sequestered in the cytosol typically by bind-
ing to their inhibitor protein IκBs in unstimulated cells. Signal-
dependent degradation of IκBs by the ubiquitin–proteasome
pathway results in the translocation of NF-κB into the nucleus,
which in turn promotes the expression of genes controlling vari-
ous cellular responses (33). RANK, CD40, and LtβR signaling are
capable of activating two distinct NF-κB pathways: the canoni-
cal NF-κB pathway and the non-canonical NF-κB pathway (16,
33). Briefly, activation of the canonical NF-κB pathway leads to
nuclear translocation of RelA or c-Rel bound to p50. On the
other hand, the non-canonical NF-κB pathway results in nuclear
translocation of RelB bound to p52.
RelB deficiency and a dysfunctional mutation of NF-κB induc-
ing kinase (NIK), a signal transducing molecule of the non-
canonical NF-κB pathway, cause a severe reduction in the number
of mature mTECs (34–37), suggesting an essential role for the
non-canonical NF-κB pathway in mTEC differentiation. TNF
receptor-associated factor 6 is a signal transducer of the canonical
NF-κB pathway and is also essential for the mTEC differen-
tiation (38). These data imply that roles of the canonical and
non-canonical NF-κB pathways are not redundant, but that both
are essential for mTEC differentiation. Elucidation of the func-
tional differences between these two NF-κB pathways in mTEC
differentiation remains to be determined.
Role of IL-22 Signaling in the Regeneration
of TECs
Many stressors, such as psychological stress, virus infection,
chemotherapy, and irradiation in bone marrow transplantation
therapy, provoke acute thymic involution in which TECs and
thymocytes rapidly decrease (39, 40). Although recovery from
these acute thymic injuries usually occurs, incomplete recovery
of thymic cells can increase the risk of immunodeficiency and
autoimmunity (39, 40). Therefore, understanding the molecular
and cellular mechanisms of acute thymic involution and its
recovery is necessary. A recent study revealed a critical role for
IL-22 in the repair of TECs after thymic involution induced by
radiation (13).
IL-22 is reportedly produced by T helper 1 (Th1) cells, Th17
cells, and Th22 cells (41, 42). In addition, group 3 ILCs secret high
amounts of IL-22 (41, 42). The IL-22 signal is transmitted through
the IL-22 receptor (IL-22R), consisting of IL-22R1 and IL-10R2
subunits, and activates various downstream signaling (41). The IL-
22 signal promotes the regeneration of epithelial cells in the liver,
airway, and intestine after injury (42).
Dudakov et al. (13) reported that expression of IL-22 is upreg-
ulated in the thymus after total body irradiation in mice, which
may mimic thymic injury by radiation therapy for malignant
leukemia. IL-22 expression showed an inverse correlation with
changes in thymic cell numbers after the irradiation. They further
demonstrated a delay of TEC recovery in IL-22-deficient mice
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(Il22 / ) after the irradiation. Because thymic cell numbers were
not reduced in the thymus of untreated Il22 /  mice, IL-22
appears to function in the regeneration of TECs specifically. They
also determined that lymphoid tissue inducer (Lti), which belongs
to group 3 ILCs, was the producer of IL-22 in this context. IL-22
expression in the Lti was induced by signaling of IL-23 secreted
from thymic DCs. The reduction of CD4+CD8+ thymocytes
(double positive, DP) by irradiation triggered the secretion of
IL-23 from DCs, although the molecular mechanism remains
unclear. IL-22 appears to enhance proliferation of mTECs as
well as cTECs. Because Aire-positive mTECs are reportedly post-
mitotic (43), it should be determined in the future whether IL-22
signaling alone is capable of inducing the proliferation of Aire-
positive mTECs in this situation or whether other signals are
necessary for the recovery of Aire-positive mTECs.
Negative Regulatory Mechanisms for
Fine-Tuning the Cellularity of mTECs
Negative Regulation of mTEC Cellularity by
TGF-β Signaling
Tumor growth factor (TGF)-β has diverse functions during the
development and homeostasis of various tissues (44). Binding
of TGF-β to its cell surface receptor complex, consisting of
type II receptors (TGF-β RII) and the type I receptors (TGF-β
RI), induces activity in its cytoplasmic serine/threonine kinases,
thereby activating Smad protein complex. The activated Smad
complex is subsequently translocated into the nucleus and pro-
motes gene expression. As a result, TGF-β signaling induces anti-
proliferative and pro-apoptotic effects in many types of cells.
In the thymus, TGF-β is expressed by cTECs and immature thy-
mocytes (45, 46). On the other hand, the TGF-β receptor complex
is expressed in both cTECs and mTECs (47). Hauri-Hohl et al.
have recently reported a role for TGF-β signaling in regulation
of mTEC number (14). They prepared mice lacking TGF-β RII
expression specifically in TECs. Interestingly, the cellularity of
only mTECs was increased by the lack of TGF-β signaling in
TECs. Consistently, administration of a TGF-β RI inhibitor also
increased themTEC number. Thus, TGF-β signaling limits mTEC
cellularity selectively, although both mTEC and cTECs should
receive the signals.
The limitation of mTEC number by TGF-β signaling is less
likely due to its anti-proliferative and pro-apoptotic effects.
Instead, in vitro data have suggested that TGF-β signaling
interferes with the activation of non-canonical NF-κB signaling;
the mechanism, however, remains unclear. Given that RANK,
CD40, and LtβR signaling all activate non-canonical NF-κB
signaling, it is possible that TGF-β inhibits non-canonical NF-κB
signaling triggered by these receptors, thereby limiting the mTEC
cellularity. This idea might explain the mTEC-selective inhibition
by TGF-β.
Regulation of Gene Expression and
Differentiation of mTECs by the ETS Family
Member Spi-B
The Ets family transcription factor Spi-B has been recently
identified as a regulator of mTEC differentiation (15). RANKL
signaling rapidly upregulates Spi-B expression in in vitro thymic
stromal culture via the NIK-dependent NF-κB pathway. Lack of
Spi-B caused an increase in the number of mTECs expressing
high levels of MHC II. On the other hand, expression of co-
stimulatory molecule CD80, CD86, and some of TSAs in mTECs
were strikingly reduced in Spi-B-deficient (Spib / ) mTECs.
Thus, Spi-B apparently has dual functions in mTEC differenti-
ation: Spi-B limits the number of mature mTECs and promotes
some mTEC-functional genes. In addition, expression of osteo-
protegerin (OPG), a decoy receptor of RANKL (48), was signifi-
cantly reduced in Spib /  mTECs. OPG was previously reported
to be a negative regulator of mTEC differentiation by inhibiting
RANKL signaling (19). Moreover, the Spi-B-mediated limitation
ofmTEC cellularity was not detected in the absence ofOPG. These
facts suggest that Spi-B induced by RANK signaling upregulates
OPG expression in mTECs, thereby competitively inhibiting the
RANKL signal-inducing mTEC differentiation (Figure 1). Thus,
this negative feedback regulation finely tunes the cellularity of
mTECs. Noticeably, negative regulation of mTEC differentiation
by the Spi-B–OPG axis starts in the peri- to neonatal period,
during which Aire mediates long-lived tolerance (49, 50).
Biological and Physiological Significance of
Negative Regulation of mTEC Cellularity
The effect of TGF-β signaling in mTECs on thymic T cell dif-
ferentiation was investigated (14). The number of SP thymocytes
and the frequency of CD4SP were mildly increased by the absence
of TGF-β signaling. Moreover, export of thymic T cells to the
periphery was delayed in the postnatal period of thesemice. These
data suggest that the increase in mTEC number prolongs the
dwelling time ofmatureT cells in the thymicmedulla. The absence
of TGF-β signaling inTECs resulted in an increase in thymicTregs
and their precursors and a reduction in the frequency of thymic
and peripheral Th17 cells.
FIGURE 1 | Negative regulation of mTEC differentiation by the
RANK–Spi-B–OPG–RANKL feedback loop. mTECs are derived from a
common progenitor that can give rise to both mTECs and cTECs. RANK
signaling promotes differentiation of relatively immature mTECs into mTECs
expressing high levels of MHC class II (MHC II), CD80, and Aire. A recent
study suggested that RANK signaling upregulates expression of Spi-B. Spi-B
promotes expression of some TSAs, CD80, and osteoprotegerin (OPG), a
secreted decoy receptor for RANK, in mTECs. OPG, in turn, competitively
inhibits RANKL–RANK interactions, thereby inhibiting the RANKL-dependent
process of mTEC differentiation.
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Osteoprotegerin-deficient (Opg / ) mice were used to inves-
tigate the role of the negative feedback circuit consisting of
RANKL–Spi-B–OPG in thymic T cell selection (15). The OPG
deletion in the thymic stroma led to an increase in the num-
ber and frequency of Tregs and Treg precursors in the thymus.
Together with the findings on TGF-β-mediated TEC regulation,
this suggested that negative regulation of mTECs attenuates the
generation of thymic Tregs. Importantly, the increase in Treg
generation by the deletion of OPG initiates in the perinatal period.
A recent study revealed that Tregs generated during this period
are functionally distinct from those produced in the adult thymus
and that these Tregs play a critical role in long-lived tolerance
induction (49, 50). Therefore, fine-tuning in the generation of
Tregs during this period by this negative feedback loop could have
an impact on T cell tolerance in adults.
What is the physiological impact of these negative regulations?
Suppose that mTECs simply played a role in preventing the onset
of autoimmune disease by negative selection and conversion of
Tregs. In this case, the inhibitory regulations of mTEC differentia-
tion might be harmful to the body. Indeed, the absence of TGF-β
signaling in TECs attenuates autoimmunity caused by a chronic
ablation of Tregs (14), suggesting a reduction of self-tissue reactive
T cells by abolishing TGF-β-mediated negative regulation. Thus,
this finding supports the idea that negative regulation of mTECs
would increase the risk of autoimmunity. Besides the critical
role of mTECs in inducing tolerance toward various self-tissues,
recent studies have shown that mTECs promote T cell tolerance
to tumors (10–12). The roles of RANKL–Spi-B–OPG negative
feedback regulation in tumor immunity were tested. When this
negative feedback loop was abolished by OPG depletion in the
thymic stroma, tumor growth, and incidence of carcinogenesis
were increased (14). These findings suggest that this negative feed-
back regulationmight promote tumor immunity and optimize the
trade-off between prevention of autoimmunity and induction of
tumor immunity. Thus, negative regulation ofmTECnumbermay
contribute to immune responses toward self-antigens in tumors
that are originally derived from self-tissues.
Perspective on Mathematical Modeling for
TEC Cellularity
As described above, many cell types andmolecules are involved in
the regulation of mTEC cellularity. Consequently, T cell selection
and tolerance induction supported by mTECs could be finely
tuned by a combination of various mechanisms under steady state
and pathological condition. Mathematical modeling would help
us to understand this complicated situation. However, mathemat-
ical modeling on dynamics of TECs, including mTECs, has not
been reported yet. On the other hand, there are several stud-
ies on mathematical modeling of thymocyte development. The
similar mathematical approach as that used for investigations into
thymocyte development can be employed for TEC development.
Moreover, because interactions with thymocytes are critical for
differentiation, proliferation, and survival of TECs, dynamics of
thymocytes should be included in the mathematical modeling
of TECs. In this section, we briefly discuss about a perspec-
tive on use of mathematical models to understand dynamics of
TEC population by referring to previous mathematical modeling
studies on thymocytes.
Generally, tracking cell fates over time at the single-cell level
is experimentally demanding and almost impossible in vivo.
Therefore, mathematical models are indispensable to extract
biologically relevant information on cellular dynamics and
differentiation from population-level measurements. As more
detailed information is obtained by new experimental methods,
the mathematical models have also evolved from simple ordinary
differential equations (ODEs) to cellular automata, compartment
models, and stochastic models in order to account for different
subtypes of lymphocytes, their cellular heterogeneity, and spatial
niches that they reside.
Although dynamics of thymocyte populations were modeled
by their types, i.e., DN, DP, and SPs, the interactions of thymo-
cytes with TECs were not explicitly incorporated in many models
(51–55). In order to investigate the contributions of cortical and
medullary selection, the influence of the TECs and the thymic
environment were incorporated more explicitly into models in
other studies. Fano et al. modeled the interaction of the thymo-
cytes with the cortical and medullary APCs to estimate the frac-
tions of the positively and negatively selected thymocytes in the
cortex and themedulla in relation to the diversity of presenting lig-
ands (56). In other studies (57, 58), the anatomical structure of the
thymus, together with cell types, was incorporated explicitly into
an investigation of the interrelation between thymocytemigration
and selection. In these studies, however, the TECswere considered
to be in a static thymic environment. In reality, the TECs also
differentiate and proliferate homeostatically in the thymus.
Influence of the thymocyte dynamics should be incorporated
into the mathematical modeling of TEC development because not
only intra- but also inter-regulation of thymocytes and TECs is
quite important when we consider the differentiation process of
TECs and recovery of TECs from damage and its involution by
aging, in which both thymocytes and TECs change their pop-
ulation dynamically (59, 60). Thus, we think that mathematical
models will be crucial for understanding the joint dynamics of
thymocytes and TECs by disentangling their complicated cell–cell
interactions.
Concluding Remarks
Several types of cells and various positive and negative signaling
pathways appear to control the cellularity ofmTECs under physio-
logical and pathological condition. Because cellular development
and recovery from injuries are time-dependent processes, these
mechanisms should be regulated in a precise and timely manner.
Employment of mathematical modeling is a promising approach
to understand these temporally regulated processes in the
future.
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